These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7046193)

  • 1. Successful treatment of human gram-negative bacteremia with antiserum against endotoxin core.
    Ziegler EJ; McCutchan JA; Douglas H; Braude AI
    Trans Assoc Am Physicians; 1981; 94():39-43. PubMed ID: 7046193
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.
    Ziegler EJ; McCutchan JA; Braude AI
    Eur J Cancer (1965); 1979; 15 Suppl():71-6. PubMed ID: 397063
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
    Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
    N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia.
    McCutchan JA; Ziegler EJ; Braude AI
    Eur J Cancer (1965); 1979; 15 Suppl():77-80. PubMed ID: 397064
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current developments in the field of infection caused by gram-negative microorganisms; passive immunization using anti-endotoxin antibodies].
    van Deventer SJ; ten Cate JW; Appelmelk BJ
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1907-10. PubMed ID: 3317073
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.
    Wortel CH; Ziegler EJ; van Deventer SJ
    Prog Clin Biol Res; 1991; 367():161-78. PubMed ID: 1924425
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis.
    Cross AS; Opal S; Cook P; Drabick J; Bhattacharjee A
    Vaccine; 2004 Feb; 22(7):812-7. PubMed ID: 15040932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in gram-negative bacterial infections.
    Lugowski C
    Acta Biochim Pol; 1995; 42(1):19-24. PubMed ID: 7653155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies against endotoxin in septicemia. Marketing or scientific evaluation?].
    Waage A
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):951-3. PubMed ID: 8191476
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with monoclonal anti-endotoxin antibodies of patients with sepsis caused by Gram-negative bacteria].
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1289-91. PubMed ID: 1861770
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive protection against X-irradiation with serum from zymosan-primed and endotoxin-injected mice.
    Addison PD; Berry LJ
    J Reticuloendothel Soc; 1981 Oct; 30(4):301-11. PubMed ID: 7031241
    [No Abstract]   [Full Text] [Related]  

  • 14. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
    Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
    J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-negative bacteraemia: new therapeutic possibilities with anti-endotoxin antibodies.
    Gaffin SL
    Haematol Blood Transfus; 1985; 29():107-11. PubMed ID: 3896966
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-endotoxin therapeutic options for the treatment of sepsis.
    Lynn WA
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():71-80. PubMed ID: 9511089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of gram-negative bacteremia with antiserum to mutant E. coli.
    Tierney WM
    N Engl J Med; 1983 Apr; 308(17):1032. PubMed ID: 6339930
    [No Abstract]   [Full Text] [Related]  

  • 18. Septicaemic low birthweight neonates treated with human antibodies to endotoxin.
    Adhikari M; Coovadia HM; Gaffin SL; Brock-Utne JG; Marivate M; Pudifin DJ
    Arch Dis Child; 1985 Apr; 60(4):382-4. PubMed ID: 3890768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
    Daifuku R; Panacek EA; Haenftling K; Swenson WK; Prescott AW; Johnson JL
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies in the treatment of sepsis caused by Gram-negative microorganisms].
    Otero AJ; Linares M
    Rev Cubana Med Trop; 1998; 50(1):31-5. PubMed ID: 9842265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.